Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.humpath.2013.09.022 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
What cancers explain the growing rural-urban gap in human papillomavirus-associated cancer incidence?
J Rural Health
January 2025
St. Jude Children's Hospital, Memphis, Tennessee, USA.
Purpose: Human papillomavirus (HPV) can cause cancers of the genital system, anus/rectum, and oropharynx. Prior research showed that HPV-associated cancer incidence was rising faster in nonmetro than in metro populations. Our study identified which cancers contributed to the widening disparity.
View Article and Find Full Text PDFPrognostic implications of immune classification based on PD-L1 expression and tumor-infiltrating lymphocytes in endocervical adenocarcinoma.
Transl Oncol
December 2024
Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou 510060, China. Electronic address:
Background: Endocervical adenocarcinoma (ECA) comprises a heterogeneous group of diseases whose incidence has increased significantly in recent decades. ECA can be histologically classified into human papillomavirus-associated (HPVA) and non-HPVA (NHPVA) types. Given the variability in pathological features and clinical behavior between the subtypes, evaluating their respective immune microenvironments is essential.
View Article and Find Full Text PDFEffect of External Beam Radiation Therapy and Brachytherapy on Circulating Myeloid-Derived Suppressor Cell Populations in Patients Treated Definitively for Cervical Cancer.
Adv Radiat Oncol
February 2025
University of Minnesota Medical School, Minneapolis, Minnesota.
Purpose: The immunosuppressive function of myeloid-derived suppressor cells (MDSCs) has been implicated in the regulation of immune responses against cancer and is associated with poor prognosis. Radiation treatment is known to alter immune cell populations within the tumor; however, whether this results in the recruitment of immunosuppressive MDSC populations is not well understood. Here we evaluate the response of circulating MDSC populations in patients treated per standard-of-care cisplatin chemoradiation therapy (CRT) for locally invasive cervical cancer.
View Article and Find Full Text PDFHuman papillomavirus associated vulval intraepithelial neoplasias: Screening for cervical dysplasia in this cohort.
J Am Acad Dermatol
December 2024
Department of Dermatology, Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom.
Impact of circulating tumor human papillomavirus DNA kinetics on disease outcomes in HPV-associated oropharyngeal cancer.
Int J Cancer
December 2024
Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Circulating tumor tissue modified (TTMV)-HPV DNA has emerged as a promising biomarker in human papillomavirus associated oropharyngeal squamous cell carcinoma (HPV-OPSCC). The objective of this study was to assess ctHPVDNA TTMV clearance kinetics during RT and its relationship with progression in HPV-OPSCC. We identified 80 non-metastatic HPV-OPSCC patients with 366 TTMV samples who underwent prospective plasma TTMV testing before, during and after curative intent RT or CRT between June 2021 and February 2023.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!